C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors: evaluating the ‘SMuRF-less but inflamed’
Over a 30-year horizon, cardiovascular events commonly occur among 'SMuRF-less but inflamed' women who are otherwise missed by current screening algorithms, a clinically important observation given recent trial data demonstrating that statin therapy reduces risk by 38% among such individuals.
Authors
- Gemma Alexandra Figtree (ORCID: https://orcid.org/0000-0002-5080-6083)
- M. Vinayaga Moorthy (ORCID: https://orcid.org/0000-0002-0983-3215)
- Samia Mora (ORCID: https://orcid.org/0000-0001-6283-0980)
- Paul M. Ridker (ORCID: https://orcid.org/0000-0003-1249-4522)
- Julie E. Buring
Institutions
- Brigham and Women's Hospital (US)
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1093/eurheartj/ehaf658
- Citations
- 13
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 17.60
Funders
- National Heart, Lung, and Blood Institute